[Clinical aspects of implantable defibrillators: indication].

The rapidity of technological progress has now made available a device which was only a dream a few years ago, a nearly ideal implantable defibrillator. Despite the persistence of a number of technical and clinical problems, the fourth generation defibrillators are multiprogrammable, with antitachycardia and antibradycardia functions, implantable by the endocavitary approach in most cases thanks to the introduction of biphasic shocks, fitted with constantly improving systems of telemetry, and are progressively smaller in size. The selection of a defibrillator device requires consideration of the patient's needs and the technical characteristics of the defibrillator. Apart from special situations in which the indications of the implantable defibrillator are generally accepted, it is only possible in the absence of results of prospective clinical trials, to use data accumulated on the place of defibrillation compared with other forms of management of severe ventricular arrhythmias. As there is a wide choice of treatment of these ventricular arrhythmias, the role of each must be defined for each individual patient. With regards to the implantable defibrillator, it is essential to take into consideration a number of clinical and paraclinical factors such as the clinical preservation of the arrhythmia, the underlying cardiac disease, left ventricular function and the type of arrhythmia induced by programmed ventricular stimulation.